Skip to content
Search

Latest Stories

RPS patient safety professional standards updated

RPS patient safety professional standards updated

These updated professional standards apply to the entire pharmacy team, regardless of setting, practice or level of expertise

The Royal Pharmaceutical Society (RPS), along with the Association of Pharmacy Technicians UK (APTUK) and the Pharmacy Forum Northern Ireland (PFNI), has revised its patient safety professional standards, extending them to include all roles and sectors within the pharmacy.

According to the RPS, these standards support pharmacists, pharmacy technicians, and pharmacy teams when responding to patient safety incidents.


The update replaces the 2016 version, called the RPS Professional standards for the reporting, learning, sharing, taking action and review of incidents.

in 2018, a legal defence for dispensing errors for registered pharmacies was introduced, which was further extended to hospitals and other pharmacy services in 2022.

The revision was overseen by an expert steering group, which incorporated feedback from both patients and specialists in patient safety.

Regina Ahmed, guidance manager, Royal Pharmaceutical Society, UK elaborated that the professional standards and guidance produced by RPS provide a framework to support pharmacy professionals and pharmacy teams to “develop their professional practice, improve services, shape future services, and deliver high quality patient care.”

"This set of evolved standards are the fruitful outcome of the collaboration between professional leadership bodies alongside patient safety subject matter experts. Their implementation will help demonstrate the patient safety culture we wish to see in all pharmacy teams,” she added.

The updated standards describe clear expectations and outcomes to help pharmacy professionals demonstrate good and effective professional practice, patient safety and systems of care, and provide support to meet regulatory standards.

Pharmacy professionals are also provided a framework for reflecting, reporting and recording incidents, sharing learning, taking action and reviewing and evaluating incidents as part of a patient safety culture.

As stated by the RPS, the new standards can also be used to “inform, develop and implement local and organisational policies and services.”

These standards should be implemented when conducting risk assessments for new services and adopting new and emerging technologies, it added.

Additionally, the update includes new supporting resources, including case studies, as well as new legislation and updated guidance from the General Pharmaceutical Council (GPhC) and NHS England.

Nicola Stockmann, President of APTUK, said that the updated standards can be used by the entire pharmacy team to “assist with professional judgement and management of events, including supporting those impacted.”

Furthermore, they can be used to identify sustainable system improvements, facilitating both shared and individual learning, he added.

Julie Greenfield, Pharmacy Forum NI Manager, said: ‘’By working together, the review and update of the standards and guidance aligns with current best practice, is relevant for all pharmacy team members and importantly ensures consistency UK-wide.’’

RPS added that pharmacy professionals who adhere to its professional standards and guidance can be assured that these measures assist in fulfilling the broader regulatory standards outlined by the GPhC.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less